PMC:7546122 / 12819-13210 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T66","span":{"begin":268,"end":274},"obj":"Body_part"},{"id":"T67","span":{"begin":323,"end":329},"obj":"Body_part"}],"attributes":[{"id":"A66","pred":"fma_id","subj":"T66","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A67","pred":"fma_id","subj":"T67","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"In clear contrast, testing the same lots of IVIG that were shown to contain high HCoV-229E nAb titers with a highly specific SARS-CoV-2 µNT did not detect SARS-CoV-2–specific nAbs. These results are entirely consistent with the absence of SARS-CoV-2 antibodies in the plasma used for production of these IVIG lots, as this plasma was donated well before the start of the SARS-CoV-2 pandemic."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T62","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"T63","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"T64","span":{"begin":239,"end":247},"obj":"Disease"},{"id":"T65","span":{"begin":371,"end":379},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"In clear contrast, testing the same lots of IVIG that were shown to contain high HCoV-229E nAb titers with a highly specific SARS-CoV-2 µNT did not detect SARS-CoV-2–specific nAbs. These results are entirely consistent with the absence of SARS-CoV-2 antibodies in the plasma used for production of these IVIG lots, as this plasma was donated well before the start of the SARS-CoV-2 pandemic."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T130","span":{"begin":19,"end":26},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T131","span":{"begin":107,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T132","span":{"begin":268,"end":274},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T133","span":{"begin":323,"end":329},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"In clear contrast, testing the same lots of IVIG that were shown to contain high HCoV-229E nAb titers with a highly specific SARS-CoV-2 µNT did not detect SARS-CoV-2–specific nAbs. These results are entirely consistent with the absence of SARS-CoV-2 antibodies in the plasma used for production of these IVIG lots, as this plasma was donated well before the start of the SARS-CoV-2 pandemic."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T94","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T95","span":{"begin":181,"end":391},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In clear contrast, testing the same lots of IVIG that were shown to contain high HCoV-229E nAb titers with a highly specific SARS-CoV-2 µNT did not detect SARS-CoV-2–specific nAbs. These results are entirely consistent with the absence of SARS-CoV-2 antibodies in the plasma used for production of these IVIG lots, as this plasma was donated well before the start of the SARS-CoV-2 pandemic."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"241","span":{"begin":81,"end":90},"obj":"Species"},{"id":"242","span":{"begin":125,"end":135},"obj":"Species"},{"id":"243","span":{"begin":155,"end":165},"obj":"Species"},{"id":"244","span":{"begin":371,"end":381},"obj":"Species"},{"id":"245","span":{"begin":239,"end":249},"obj":"Species"}],"attributes":[{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"Tax:11137"},{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"Tax:2697049"},{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:2697049"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:2697049"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In clear contrast, testing the same lots of IVIG that were shown to contain high HCoV-229E nAb titers with a highly specific SARS-CoV-2 µNT did not detect SARS-CoV-2–specific nAbs. These results are entirely consistent with the absence of SARS-CoV-2 antibodies in the plasma used for production of these IVIG lots, as this plasma was donated well before the start of the SARS-CoV-2 pandemic."}